InsiderSignalSign in

← Insider buys

MEDP

Medpace Holdings, Inc. · Healthcare

Insiders sold $374.8M of Medpace Holdings, Inc. in the last 12 months and bought none

$0Bought, 12 mo

$374.8MSold, 12 mo

$18.7BMarket cap

MEDP over the last year

No insider buys filed in this year

MEDP after insider buys

3 months after each buy, from the first price a copier could get.

+26.0%Average

+26.9 ptsVs S&P 500

9 of 11Higher

11 buys since 2022 with 3 months of prices.

Congress

Members reported 15 trades in MEDP since 2023.

Every filing

290 insider filings since 2017, newest first

August J. Troendle · President and CEO

$30.3M−12.6%Oct 1

August J. Troendle · President and CEO

$1.6M−0.7%Sep 29

August J. Troendle · President and CEO

$27.4M−10.1%Sep 25

August J. Troendle · President and CEO

$44.4M−14.1%Sep 23

August J. Troendle · President and CEO

$6.7M−2.1%Sep 21

August J. Troendle · President and CEO

$15.4M−4.6%Sep 17

August J. Troendle · President and CEO

$403K−0.1%Aug 31

Robert O. Kraft · Director

$2.4M−80.2%Aug 28

August J. Troendle · President and CEO

$2.9M−0.9%Aug 27

August J. Troendle · President and CEO

$10.0M−2.8%Aug 25

Kevin M. Brady · CFO and Treasurer

$2.1M−20.9%Aug 24

August J. Troendle · President and CEO

$26.3M−7.1%Aug 21

Brian T Carley · Director

$3.0M−15.2%Aug 21

Fred B Davenport Jr · Director

$4.4M−65.7%Aug 21

August J. Troendle · President and CEO

$7.1M−1.9%Aug 14

Cornelius P. Mccarthy III · Director

$690K−8.5%Aug 13

August J. Troendle · President and CEO

$14.0M−3.6%Aug 12

Cornelius P. Mccarthy III · Director

$465K−5.6%Aug 11

August J. Troendle · President and CEO

$4.3M−1.1%Jul 29

Susan E Burwig · Exec. VP, Operations

$4.5M−10.6%Jul 29

Stephen P Ewald · General Counsel & Corp. Secy.

$7.4M−44.6%Jun 1

Jesse J Geiger · President

$14.4M−68.0%Mar 19

August J. Troendle · CEO and 10% owner

August J. Troendle · CEO and 10% owner

$17.1M−1.0%Dec 3

August J. Troendle · CEO and 10% owner

$34.1M−1.0%Dec 1

August J. Troendle · CEO and 10% owner

$62.0M−2.0%Nov 26

Susan E Burwig · EVP, Operations

$12.2M−42.0%Nov 26

Kevin M. Brady · CFO and Treasurer

$1.8M−34.0%Nov 25

August J. Troendle · CEO and 10% owner

$17.0M−1.0%Nov 24

Robert O. Kraft · Director

$3.2M−94.0%Aug 26

Susan E Burwig · EVP, Operations

$3.1M−51.0%Jun 7

August J. Troendle · CEO and 10% owner

August J. Troendle · CEO and 10% owner

August J. Troendle · CEO and 10% owner

$15.9M−1.0%May 17

August J. Troendle · CEO and 10% owner

August J. Troendle · CEO and 10% owner

August J. Troendle · CEO and 10% owner

$21.1M−1.0%May 8

August J. Troendle · CEO and 10% owner

August J. Troendle · CEO and 10% owner

Susan E Burwig · EVP, Operations

$41K−1.0%Mar 19

Ashley M. Keating · Director

$102K−50.0%Mar 18

August J. Troendle · CEO and 10% owner

$82.3M−3.0%Mar 8

Medpace Investors, LLC · 10% owner

$82.3M−4.0%Mar 8

Ashley M. Keating · Director

$196K−100.0%Mar 8

August J. Troendle · CEO and 10% owner

$40.3M−2.0%Mar 6

Jesse J Geiger · President

$9.0M−51.0%Mar 6

Medpace Investors, LLC · 10% owner

$40.3M−2.0%Mar 6

August J. Troendle · CEO and 10% owner

$40.0M−2.0%Mar 4

Medpace Investors, LLC · 10% owner

$40.0M−2.0%Mar 4

Stephen P Ewald · GC, Corp. Secy.

$598K−10.0%Mar 1

About Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.